U.S. Insurers Could Spend Millions for Ivermectin Rx for COVID-19
Claims data for private insurance and Medicare Advantage plans show spike in inappropriate ivermectin prescriptions for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.